Predominance of the Rare EGFR Mutation p.L861Q in Tunisian Patients with Non-Small Cell Lung Carcinoma

Predominance of the Rare EGFR Mutation p.L861Q in Tunisian Patients with Non-Small Cell Lung Carcinoma

Objectives: Several new cancer therapies targeting signaling pathways involved in the growth and progression of cancer cells were developed as personalized medicine. Our study aimed to identify epidermal growth factor receptor (<i>EGFR</i>) mutations for TKI treatment in non-small-cell l...

Full description

Bibliographic Details
Main Authors: Rania Abdelmaksoud-Dammak, Nihel Ammous-Boukhris, Amèna Saadallah-Kallel, Slim Charfi, Souhir Khemiri, Rim Khemakhem, Nesrin Kallel, Wala Ben Kridis-Rejeb, Tahya Sallemi-Boudawara, Afef Khanfir, Ilhem Yangui, Jamel Daoud, Raja Mokdad-Gargouri
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Genes
Subjects:
non-small-cell lung carcinoma
epidermal growth factor receptor
mutation
pyrosequencing
tyrosine kinase inhibitors
targeted therapy
Online Access:https://www.mdpi.com/2073-4425/13/8/1499

Internet

https://www.mdpi.com/2073-4425/13/8/1499

Similar Items